Effect of estrogen on telomere length in peripheral blood leukocytes
CSTR:
Author:
Affiliation:

(Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Key Laboratory of Endocrinology, National Health Commission,Beijing 100730, China)

Clc Number:

Fund Project:

This project was supported by Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(CIFMS2016-I2M-4-001) andthe Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019PT320007).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Telomeres undergo attrition with each cell division. Leukocyte telomere length (LTL) and telomerase activity have been extensively investigated in a variety of diseases, such as cardiovascular disease and related metabolic risk factors, neurological disorders, and malignancies. Telomere length may be determined by various factors, including the genetic load and environmental factors. At birth, gender difference in the telomere length is not significant, but telomeres are longer in women than in men. This gender discrepancy is probably caused by the effects of endogenous estrogen exposure or hormone replacement treatment (HRT). Estrogen is known to be antioxidant and may increase telomerase activity; therefore, knowledge about the associate between estrogen and telomere length helps explore therapies targeting the telomere-telomerase system as promising treatment for age-related diseases.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 16,2020
  • Revised:
  • Adopted:
  • Online: May 28,2021
  • Published:
Article QR Code